VE-BEVS Complete Kit 30022 (VE-CL-02, pAcVE.02)

30022

Email Purchase Order

VE-BEVS Complete Kit 30022 contains Product 10020 Insect Cell Line (VE-CL-02) and Product 20020 Transfer Vector (pAcVE.02).

• VE-BEVS Insect Cell Line 10020 (1x10⁷ cells; frozen) (VE-CL-02) Enhanced expression of highly unstable or toxic proteins.

• VE-BEVS Transfer Vector 20020 (10 µg) (pAcVE.02) Co-expression of 𝘷𝘢𝘯𝘬𝘺𝘳𝘪𝘯 gene for increased protein production; HBM signal sequence for direct secretion and N-terminal 8xHis-tag for ease of purification of protein of interest.

Advantages

VE-BEVS Insect Cell Line 10020

  • Engineered monoclonal Sf9 cell line stably expresses a vankyrin gene.
  • Mycoplasma free
  • Up to 7.5-fold increase in protein yield as compared to parental Sf9 cells
  • Enhanced protein expression occurs at a very high level over a very short time interval
  • Prolonged longevity of cells after infection with a baculovirus compared to parental Sf9 cells
  • Increased baculovirus titer
  • Compatible with all conventional BEVS
  • Reduced cost and labor
  • Expression of recombinant protein may need to be optimized by testing different time points and MOIs.

Transfer Vector 20020 (pAcVE.02)

  • This baculovirus transfer vector integrates the co-expression of a vankyrin gene from the p10 promoter for the increased production of gene of interest from the polyhedrin promoter with:

    • Honey bee melittin signal sequence for direct secretion and
    • N-terminal 8x his-tag for ease of purification

      Documents

      VE-BEVS Cell Line Instructions [PDF]

      Transfer Vector pAcVE.02 [PDF]

      pAcVE.02 Instructions [PDF]

      VE-BEVS Cell Line FAQs [PDF]

      VE-BEVS Licensing

      Contract service for introducing the vankyrin gene into a custom insect cell line is available upon request.

      Patent information:
      VE-BEVS Cell Line United States Patent 7,842,493 [PDF]
      VE-BEVS Transfer Vector United States Patent 7,629,160 [PDF]

      Back to the top